NBIX Market Cap & Key Metrics
Neurocrine Biosciences, Inc.
$172.33
-$2.08(-1.19%)
72
Overall
70
Value
75
Tech
71
Quality
Market Cap
$17.44B
Volume
411.46K
52W Range
$122.14 - $186.12
Target Price
$206.66
NBIX market cap is $17.44B. This page lists Neurocrine Biosciences, Inc.'s P/E ratio, EPS estimates, dividend yield, payout ratio and MarketXLS scores.
NBIX Key Metrics
- Market cap
- $17.44B
- P/E ratio (current-year EPS estimate)
- 20.49
- EPS estimate, current year
- $8.41
- EPS growth, 3-year
- +44.03%
- Value score
- 70
- Quality score
- 71
- Technical score
- 75
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $2.86B | $2.36B | $1.89B | $1.49B | $1.13B |
| EBITDA | $666.60M | $513.10M | $353.40M | $237.80M | $138.10M |
| EPS | $4.81 | $3.40 | $2.56 | $1.61 | $0.95 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | NBIX | $172.33 | -1.2% | 411.46K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Neurocrine Biosciences, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW